Natural killer cells in relapsing-remitting MS

Longitudinal data analysis using generalized linear models

1986 • 17,084 citations

Longitudinal Data Analysis for Discrete and Continuous Outcomes

1986 • 7,710 citations

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

1993 • 2,032 citations

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

1993 • 1,908 citations

A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1).

1981 • 1,411 citations

The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.

1986 • 1,106 citations

Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.

1983 • 852 citations

Comparative studies of human FcRIII-positive and negative natural killer cells.

1989 • 688 citations

Interferon β‐1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase‐9

1996 • 363 citations

The role of natural killer cells in human disease

1989 • 224 citations

Towards a better definition of human leucocyte surface molecules

1989 • 198 citations

Role of human natural killer cells in health and disease

1994 • 179 citations

Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen).

1985 • 171 citations

Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor.

1980 • 167 citations

Correlation of Functional Properties of Human Lymphoid Cell Subsets and Surface Marker Phenotypes Using Multiparameter Analysis and Flow Cytometry

1983 • 165 citations

Evidence for three types of human cytotoxic lymphocyte

1986 • 149 citations

Interfer beta augments supperssor cell function in multiple sclerosis

1990 • 120 citations

A role for natural killer cells in the immunopathogenesis of multiple sclerosis

1998 • 95 citations

Molecular, Functional and Biochemical Characteristics of the Dopamine Transporter

1994 • 93 citations

In vitro and in vivo inhibition of mitogen‐driven T‐cell activation by recombinant interferon beta

1993 • 91 citations

Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis.

1982 • 83 citations

Decreased NK killing in patients with multiple sclerosis: an analysis on the level of the single effector cell in peripheral blood and cerebrospinal fluid in relation to the activity in the disease.

1982 • 83 citations

Natural killer cell activity in multiple sclerosis.

1981 • 79 citations

Cytotoxic activity and interferon production by lymphocytes from patients with multiple sclerosis.

1981 • 74 citations

Recent progress in interferon research: molecular mechanisms of regulation, action, and virus circumventin

1990 • 72 citations

Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls

1995 • 64 citations

Interferon Beta in Multiple Sclerosis

1996 • 63 citations

Spontaneous cell-mediated cytotoxicity in humans. Distribution and characterization of the effector cell.

1978 • 62 citations

Differential Phenotypic Properties of Human Peripheral Blood CD56<sup>dim+</sup> and CD56<sup>bright+</sup> Natural Killer Cell Subpopulations

1996 • 62 citations

Non-MHC-Restricted Cell-Mediated Lysis of Human Oligodendrocytes In Vitro: Relation with CD56 Expression

1998 • 58 citations

Progressive multiple sclerosis: Abnormal immune functions in vitro and aberrant correlation with enumeration of lymphocyte subpopulations

1986 • 45 citations

NK cell proliferation and inflammation

1996 • 42 citations

Natural killer cells activity in patients with multiple sclerosis given ? interferon

1983 • 36 citations

The effect of recombinant alpha ₂ ‐interferon on defective natural killer cell activity in multiple sclerosis

1985 • 29 citations

Natural killer cell activity in multiple sclerosis patients treated with recombinant interferon-α2

1985 • 28 citations

Natural killer (NK) cells in chronic progressive multiple sclerosis patients treated with lymphoblastoid interferon

1988 • 23 citations

Fine analysis of cytolytic and natural killer T lymphocytes in the CSF in multiple sclerosis and other neurologic diseases

1987 • 19 citations

Natural Killer (NK) Activity in Human Responders and Nonresponders to Stimulation by Anti-CD16 Antibodies

1995 • 17 citations

Physiological Mechanisms of Production and Action of Interferons in Response to Viral Infections

1989 • 10 citations